Download PDF
Horm Metab Res 2022; 54(09): 587-592
DOI: 10.1055/a-1882-8423
Original Article: Endocrine Care

A Systematic Review and Meta-Analysis of Metabolic Syndrome Prevalence in Chinese Inpatients with Bipolar Disorder

Hejian Tao 
1   Psychiatry Department, Zhejiang Chinese Medical University, Hangzhou, China
,
Dong Shen
2   Psychiatry Department, Jiaxing Kangci Hospital, Jiaxing, China
,
Yong Zhou
2   Psychiatry Department, Jiaxing Kangci Hospital, Jiaxing, China
,
Fengli Sun
3   Psychiatry Department, Zhejiang Province Mental Health Center, Hangzhou, China
,
Guorong Li
2   Psychiatry Department, Jiaxing Kangci Hospital, Jiaxing, China
,
Weidong Jin
1   Psychiatry Department, Zhejiang Chinese Medical University, Hangzhou, China
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

The aim of the work was to study the prevalence of metabolic syndrome in Chinese patients with bipolar disorder. We searched Chinese literature related to the study in prevalence of metabolic syndrome in bipolar disorder in Chinese language, among which results such as comments, letters, reviews and case reports were excluded. The prevalence of metabolic syndrome in bipolar disorder was researched and discussed. A total of 1562 subjects were included in 11 studies. The prevalence of MetS in bipolar disorder was 33% (95% CI=0.29–0.37), which was higher significantly than normal control (10.82%), but similar to schizophrenia (31.59%). The 41.41% prevalence of MetS in male patients was higher significantly than that in females (26.83%).The prevalence of MetS in BD treated by AAP was 47.54%, by MS was 19.19%, by MS+AAP was 40%.The prevalence of MetS in BD treated by carbamazepine was 28.21%, by lithium was 30%, by valproate was 21.71%, by clozepine was 51.43%, by olanzapine was 39.84%, by quetiapine was 39.44%, and by risperidone was 35%. The prevalence of MetS in bipolar disorder was 33% (95% CI=0.29–0.37), which was higher significantly than normal control (10.82%), but similar to schizophrenia (31.59%). AAP and MS were the main one risks of MetS in BD.

Key words

bipolar disorder - metabolic syndrome - meta-analysis - systematic review


Publication History

Received: 12 April 2022

Accepted after revision: 23 June 2022

Accepted Manuscript online:
23 June 2022

Article published online:
20 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018; 20: 12
    Google Scholar
  • 2 Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome. J Cardiovasc Pharmacol Ther 2017; 22: 365-367
    CrossrefPubMedGoogle Scholar
  • 3 Aguilar M, Bhuket T, Torres S. et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015; 313: 1973 1974
    CrossrefPubMedGoogle Scholar
  • 4 Li R, Li WH, Lun ZJ. et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health 2016; 16: 296
    CrossrefPubMedGoogle Scholar
  • 5 Freund N, Juckel G. Bipolar disorder: its etiology and how to model in rodents. Methods Mol Biol 2019; 2011: 61-77
    CrossrefPubMedGoogle Scholar
  • 6 Brietzke E, Kapczinski F, Grassi-Oliveira R. et al. Insulin dysfunction and allostatic load in bipolar disorder. Expert Rev Neurother 2011; 11: 1017-1028
    CrossrefPubMedGoogle Scholar
  • 7 de Almeida KM, Moreira CLRL, Lafer B. Bipolar disorder: what should psychiatrists know?. CNS Neurosci Ther 2012; 18: 160-166
    CrossrefPubMedGoogle Scholar
  • 8 McElroy SL, Keck PE. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 2014; 75: 46-61
    CrossrefPubMedGoogle Scholar
  • 9 Li BL, Jin WD. Risks of metabolic syndrome in bipolar disorder. Clin J Psychosom Dis 2012; 25: 470-472
    PubMedGoogle Scholar
  • 10 Zhu J, Xiao WB, Dai XL. Correlation between CRP expression and MS in patients with schizophrenia and bipolar disorder. J Clin Psychosom Dis 2020; 26: 21-24
    PubMedGoogle Scholar
  • 11 Xiang H, Mao RZ, Zhao GQ. et al. Cormorbid metabolic syndrome and its risk factors of patients with bipolar disorder. Chin J Psychiatry 2017; 50: 107-112
    PubMedGoogle Scholar
  • 12 Czepielewski L, Filho LD. Brietzke et al. Bipolar disorder and metabolic syndrome: a systematic review. J Psychiatry 2013; 35: 88-93
    PubMedGoogle Scholar
  • 13 Dalkner N, Bengesser SA, Birner A. et al. Metabolic syndrome impairs executive function in bipolar disorder. Front Neurosci 2021; 15: 717824
    CrossrefPubMedGoogle Scholar
  • 14 Kocakaya IH, Songur E, Batmaz S. et al. Impact of metabolic syndrome and clinical features on functioning in patients with bipolar disorder: a cross-sectional study. Braz J Psychiatry 2020; 42: 373-381
    CrossrefPubMedGoogle Scholar
  • 15 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012
    Google Scholar
  • 16 Celiac disease. Rockville: agency for healthcare research and quality (US); 2004. https://www.ncbi.nlm.nih.gov/books/NBK35149/
  • 17 Zhang XM, Chen JX, Zhang LC. et al. Investigation of metabolic syndrome in inpatients with bipolar disorder. J Clin Psychiatry 2015; 25: 248-250
    PubMedGoogle Scholar
  • 18 Chen HH, Zhu YP, Lai KX. et al. Analysis of risk factors of metabolic syndrome in inpatients with bipolar disorder. Guangdong Med J 2018; 39: 3373-3376
    PubMedGoogle Scholar
  • 19 Huan GH, Liu HR, Zhang JP. et al. The prevalence of metabolic syndrome and lifestyle in bipolar disorder patients. Chin Behav Med. Brain Sci 2010; 19: 601-603
    PubMedGoogle Scholar
  • 20 Zhou DM. Comparison of prevalence of metabolic syndrome between patients with bipolar disorder and schizophrenia. Med J Chin People Health 2011; 23: 1496-1497
    PubMedGoogle Scholar
  • 21 Fang YY, Zhou W, Sun N. et al. Effects of metabolic syndrome on clinical prognosis of patients with bipolar disorder. Med J Chin People Health 2017; 29: 4-18
    PubMedGoogle Scholar
  • 22 Zhang DC, Hu XL. Prevalence investigation and analysis of risk factors related cormorbid metabolic syndrome in patients with bipolar disorder. Fam Med 2020; 9: 387-388
    PubMedGoogle Scholar
  • 23 Zhang BT, Qian J. Atypical antipsychotic drugs for patients with bipolar disorder and metabolism research. China Health Indust 2013; 3: 16-18
    PubMedGoogle Scholar
  • 24 Liu L, Qin XX, Xie SF. et al. Metabolic syndrome in bipolar patients with atypical antipsychotics. Chin Gen Pract 2007; 10: 1243-1244
    PubMedGoogle Scholar
  • 25 Li JH, Zhong H, Wang SK. et al. Risk factors for metabolic syndrome in patients with bipolar disorder. Shanghai Arch Psychiatry 2009; 21: 209-212
    PubMedGoogle Scholar
  • 26 Grover S, Mehra A, Chakravarty R. et al. Change in prevalence of metabolic syndrome in patients with bipolar disorder. Asian J Psychiatry 2020; 47: 101876
    CrossrefPubMedGoogle Scholar
  • 27 Li C, Birmaher B, Rooks B. et al. High prevalence of metabolic syndrome among adolescents and young adults with bipolar disorder. J Clin Psychiatry 2019; 80: 18m12422
    PubMedGoogle Scholar
  • 28 Mohite S, Wu H, Sharma S. et al. Higher prevalence of metabolic syndrome in child-adolescent patients with bipolar disorder. Clin Psychopharmacol Neurosci 2020; 18: 279-288
    CrossrefPubMedGoogle Scholar
  • 29 Nayerifard R, Bureng MA, Zahiroddin A. et al. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder. Diabetes Metab Syndr 2017; 11 (Suppl 1): S411-S416
    CrossrefPubMedGoogle Scholar
  • 30 de Jong M, Belleflamme J, Dale C. et al. Metabolic syndrome in Dutch patients with bipolar disorder: a cross-sectional study. Prim Care Companion CNS Disord 2018; 20: 18m02366
    CrossrefPubMedGoogle Scholar
  • 31 Vancampfort D, Vansteelandt K, Correll UC. et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013; 170: 265-274
    CrossrefPubMedGoogle Scholar
  • 32 Mazereel V, Detraux J, Vancampfort D. et al. Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness. Front Endocrinol (Lausanne) 2020; 11: 573479
    CrossrefPubMedGoogle Scholar
  • 33 Barton BB, Zagler A, Engl K. et al. Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in psychiatry (MiP) study. Eur Arch Psychiatry Clin Neurosci 2020; 270: 597-609
    CrossrefPubMedGoogle Scholar
  • 34 Dolab N, Kamkar MZ, Amiriani T. et al. The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid. Heliyon 2020; 6: e04553
    CrossrefPubMedGoogle Scholar
  • 35 Cerit C, Vural MM, Gelmez SÜB. et al. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study. Psychopharmacol Bull 2010; 43: 22-36
    PubMedGoogle Scholar